Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OK/Tulsa
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Tulsa, OK

Studies commonly pay $75 to $4,500 per completed study

182 clinical trials are currently recruiting participants within 30 miles of Tulsa. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

182studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Tulsa right now

Top 25 of 182 recruiting studies, sorted by proximity — each links to its official registry page

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

The Purpose of This Study is to Evaluate Efficacy and Safety of NT-101 Eye Drops in Patients With Wet Age-Related Macular Degeneration (AMD)

Wet Age Related Macular Degeneration Phase 2 Interventional 66 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi) · Sponsor: NexThera Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07811726)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082) — Tulsa, Oklahoma (5.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT03486873)

Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

Treatment-Resistant Depression N/A Interventional 140 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi) · Sponsor: Laureate Institute for Brain Research, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07166289)

Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression

Depression Phase 2 Interventional 75 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi) · Sponsor: Laureate Institute for Brain Research, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06263660)

Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

AMI Cardiogenic Shock N/A Observational 350 participants sought
Saint Francis Hospital — Tulsa, Oklahoma (5.3 mi) · Sponsor: Abiomed Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06964685)

Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility

Normal and Diseased Tissue and Body Fluids Samples N/A Observational 100,000 participants sought
St. Jude Affiliate Clinic at Saint Francis Children's Hospital — Tulsa, Oklahoma (5.3 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT01354002)

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic, Cancer N/A Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Tulsa, Oklahoma (5.3 mi) · Sponsor: Massive Bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT03452774)

The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

Mitral Annular Calcification, Mitral Stenosis N/A Interventional 210 participants sought
Oklahoma Heart Institute Utica Office — Tulsa, Oklahoma (5.3 mi) · Sponsor: Mayra Guerrero
See eligibility & contact on ClinicalTrials.gov (NCT04408430)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC — Tulsa, Oklahoma (5.3 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06246916)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Psoriatic Arthritis, Overweight or Obesity Phase 4 Interventional 200 participants sought
Essential Medical Research — Tulsa, Oklahoma (5.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06864026)

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Alopecia Areata Phase 3 Interventional 1,330 participants sought
Vital Prospects Clinical Research Institute, PC — Tulsa, Oklahoma (5.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06873945)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0041) — Tulsa, Oklahoma (5.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Cervical Cancer Phase 4 Interventional 100 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC — Tulsa, Oklahoma (5.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06952660)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05256225)

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma Phase 3 Interventional 70 participants sought
Urologic Specialists of Oklahoma — Tulsa, Oklahoma (5.3 mi) · Sponsor: UroGen Pharma Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06774131)
Actively enrolling

Studies you may be able to join near Tulsa

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Tulsa

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Ascension St. John Clinical Research

1725 E 19th St #701, Tulsa, OK 74104
(918) 744-3426

OSU Center for Health Sciences, Clinical Research

1631 S Utica Ave, Tulsa, OK 74104
(918) 586-4737

Hardesty Center for Clinical Research and Neuroscience

★ 5.0
1013 E 66th Pl, Tulsa, OK 74136
(539) 325-6560
"The HBCD study has been an awesome endeavor and the people we work with there are amazing!"
— Jamie Crawford, 5★

Delricht Research of Tulsa Clinical Trials

★ 4.8
10100 S Mingo Rd, Tulsa, OK 74133
(918) 932-2276
"Miguel was professional, friendly, and explained the processes and procedures well. He is also one of the best at drawing blood that I’ve dealt with.…"
— Wayne Bates, 5★

Clinical Pharmaceutical Trials

1705 E 19th St #406, Tulsa, OK 74104
(918) 743-4374

Central States Research

★ 4.7
7318 S Yale Ave, Tulsa, OK 74136
(918) 645-5400
"I made an appointment to see if I qualified for a paid research study. They did an assessment and determined that I didn’t meet the threshold for the…"
— Callie Spencer, 5★

Vital Prospects Clinical Research Institute

7307 S Yale Ave #200, Tulsa, OK 74136
(918) 392-4550

Laureate Institute for Brain Research

★ 4.6
6655 S Yale Ave, Tulsa, OK 74136
(918) 502-5100
"I've made good side money by being a paid participant in one of their brain research studies. The staff has been very kind, professional, and helpful."
— Joel Meine, 5★

Essential Medical Research (EMR)

★ 4.8
4765 E 91st St Ste 200, Tulsa, OK 74137
(918) 645-1992
"Thanks to Whitney Little, her attention to detail and professionalism is admirable."
— Miguel Cardiel, 5★

Clinical trials in Tulsa: what's recruiting

The Tulsa area currently has 182 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Tulsa, the most active research areas are:

  • Cancer & Oncology10 studies
  • Brain & Mental Health4 studies
  • Heart & Vascular1 studies
  • Liver & Kidney1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Tulsa, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Tulsa

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Tulsa participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Tulsa?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Tulsa?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Tulsa?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Tulsa.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Tulsa typically complete one or two studies per year.

Paid clinical trials near Tulsa

Other metros within reach

Fayetteville, AR124 Oklahoma City, OK635 Wichita, KS160 Springfield, MO147 Topeka, KS111 Olathe, KS1,039 Overland Park, KS1,030 McKinney, TX457

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Tulsa Bladder Issues Due To Spinal Cord Injury in Tulsa All conditions

More of OK

Oklahoma City635

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts